Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rcapper
    Member
    • Sep 2011
    • 20

    #1

    Permutation Strategies for RAD population genomics

    I have a set of RAD data sampled from many individuals from several populations and I would like to calculate various population genetics statistics continuously along the genome with the ultimate goal of identifying regions of the genome that may be under selection.

    I currently have a vcf file containing all genotyped bases including invariant sites, and I have developed a few scripts to calculate the stats I'm interested in from that file. Calculating the statistics the first time is easy, but the literature suggests that this is not enough. GWAS literature typically permutes the case/control (in my situation, "population") labels, generates a bootstrap sample via sampling with replacement, and recalculates the statistic, then repeats this process many times to produce a smooth distribution for this particular statistic under neutral expectations.

    This is pretty much what Stacks already does very nicely. However, for several reasons, Stacks won't work with my Type II B RAD data.

    And I cannot use the otherwise excellent vcftools package to calculate some of my statistics such as pi or Tajima's D, because it assumes that any base that is omitted from the vcf (as in, not genotyped) is invariant, which is most definitely not true for my data. Additionally, vcftools is more of a first-pass tool, and while I could probably work it into a pipeline, it doesn't do permutation/bootstrapping/etc by itself.

    I am hoping that someone may have encountered similar problems using GWAS approaches for population genetics/population genomics and may have some advice for me.

    Namely,

    1) Are there any existing tools besides Stacks and BayeScan (model-based approach for Fst) that do what I'm trying to do already?

    2) Is this permute-bootstrap-recalc per locus strategy the best approach? Basically, my strategy is to develop a null distribution per each locus; Hohenlohe et al 2010, at least for pi, heterozygosity, Fst, and rho, generated a genome-wide null distribution via calculating the stats once per locus, then sampling those values from across the genome, weighting for sample size, to develop the genome-wide null distribution.

    As a third option, someone suggested that simply testing for autocorrelation/LD among my pop gen statistics may be enough (i.e., "do I expect to see these three SNPs with a value greater than X as neighbors, or could this happen by chance?"). I'm not convinced; also, this approach necessitates defining whatever "X" cutoff you're using in some manner.

    Which approach is more robust? I think that the per-locus approach may be more conservative, and may also produce fewer false positives... but I am also terrible at statistics. Thoughts? Alternatives?

    3) Regardless of strategy, how many times should the resampling process be repeated? Until the null distribution "looks smooth enough"? How can this be tested?

    4) What are the benefits of using a sliding window approach? I understand the kernel smoothing idea where one weights each point's value by both the value and distance of the statistics at neighboring SNPs, and I like it -- but is it appropriate to use if my null distribution is locus-specific and not genome-wide?

    Thank you for any hints, comments or advice you can give me!
    Roxana
  • catchen
    Junior Member
    • Nov 2013
    • 1

    #2
    2bRAD, Stacks, and Fst

    Hi Roxana,

    What about the 2bRAD data makes it not useable in Stacks? I know that the demultiplexing/cleaning program in Stacks (process_radtags) does not yet support 2bRAD data, but I assume you have cleaned and demultiplexed your data already. Are there other factors that make Stacks unable to process it?

    I don't have any 2bRAD data myself but would like to see it supported by our software.

    Best,

    julian

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...